| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
| mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0004 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.84 |
0.0006 |
| mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0008 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.002 |